サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1769908

幹細胞の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)

Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 212 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
幹細胞の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)
出版日: 2025年05月26日
発行: Transparency Market Research
ページ情報: 英文 212 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

幹細胞市場 - 分析範囲

TMRの調査レポート「世界の幹細胞市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界の幹細胞市場の収益と予測を提供します。また、2025年から2035年までの世界の幹細胞市場の複合年間成長率（CAGR、%）も掲載しています。

当レポートは広範な調査を経て作成されています。一次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、幹細胞市場を推察しました。

市場概況
市場規模（2024年） 925億米ドル
市場規模（2035年） 2,802億米ドル
CAGR 10.5%

当レポートでは、世界の幹細胞市場の競合情勢について分析しています。世界の幹細胞市場で事業を展開する主要企業が特定され、各企業がさまざまな属性でプロファイルされています。企業概要・財務状況・最新動向・SWOTが、当レポートで紹介されている世界の幹細胞市場における各企業の属性です。

目次

第1章 序論

第2章 前提条件と分析手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の幹細胞市場分析と予測（2020～2035年）

第5章 主要洞察

  • 主要な業界イベント（パートナーシップ、コラボレーション、企業合併・買収 (M&A) など）
  • 幹細胞の概要
  • パイプライン分析
  • ポーターのファイブフォース分析
  • PESTEL分析
  • 主要国・地域別の規制シナリオ
  • バリューチェーン分析
  • 価格動向
  • 主要競合が提供する製品のベンチマーク
  • 新規市場参入者のための市場開拓戦略

第6章 世界市場の分析と予測：細胞の種類別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：細胞の種類別（2020～2035年）
    • 胚性幹細胞（ESC）
    • 間葉幹細胞（MSC）
    • 造血幹細胞
    • 人工多能性幹細胞（iPSC）
    • その他
  • 市場の魅力：細胞の種類別

第7章 世界市場の分析と予測：用途別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：用途別（2020～2035年）
    • 研究
    • 臨床
  • 市場の魅力：用途別

第8章 世界市場の分析と予測：適応症別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：適応症別（2020～2035年）
    • 筋骨格系障害
    • 心血管疾患
    • 腫瘍学
    • 炎症性疾患・自己免疫疾患
    • 神経疾患
    • その他
  • 市場の魅力：適応症別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：エンドユーザー別（2020～2035年）
    • 病院
    • 製薬・バイオテクノロジー企業
    • その他
  • 市場の魅力：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な分析結果
  • 市場予測（金額ベース）：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第11章 北米市場の分析と予測

  • 米国
  • カナダ

第12章 欧州市場の分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第13章 アジア太平洋市場の分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋

第14章 ラテンアメリカ市場の分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ

第15章 中東・アフリカ市場の分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第16章 競合情勢

  • 市場企業・競合マトリックス（企業の階層別・規模別）
  • 市場シェア分析：企業別（2024年）
  • 企業プロファイル
    • PromoCell
    • AcceGen
    • Bio-Techne
    • Cellular Engineering Technologies, Inc.
    • Merck KGaA
    • Lonza
    • Miltenyi Biotec
    • STEMCELL Technologies.
    • StemBioSys, Inc.
    • CORESTEMCHEMON Inc.
    • PHARMICELL Co., Ltd
    • BlueRock Therapeutics LP
図表

List of Tables

  • Table 01: Global Stem Cells Market Value (US$ Bn) Forecast, By Cell Type, 2020 to 2035
  • Table 02: Global Stem Cells Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 03: Global Stem Cells Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 04: Global Stem Cells Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 05: Global Stem Cells Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 06: North America Stem Cells Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 07: North America Stem Cells Market Value (US$ Bn) Forecast, by Cell Type, 2020 to 2035
  • Table 08: North America Stem Cells Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 09: North America Stem Cells Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 10: North America Stem Cells Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 11: Europe Stem Cells Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 12: Europe Stem Cells Market Value (US$ Bn) Forecast, by Cell Type, 2020 to 2035
  • Table 13: Europe Stem Cells Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 14: Europe Stem Cells Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 15: Europe Stem Cells Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 16: Asia Pacific Stem Cells Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 17: Asia Pacific Stem Cells Market Value (US$ Bn) Forecast, by Cell Type, 2020 to 2035
  • Table 18: Asia Pacific Stem Cells Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 19: Asia Pacific Stem Cells Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 20: Asia Pacific Stem Cells Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 21: Latin America Stem Cells Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 22: Latin America Stem Cells Market Value (US$ Bn) Forecast, by Cell Type, 2020 to 2035
  • Table 23: Latin America Stem Cells Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 24: Latin America Stem Cells Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 25: Latin America Stem Cells Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 26: Middle East & Africa Stem Cells Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 27: Middle East & Africa Stem Cells Market Value (US$ Bn) Forecast, by Cell Type, 2020 to 2035
  • Table 28: Middle East & Africa Stem Cells Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 29: Middle East & Africa Stem Cells Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 30: Middle East & Africa Stem Cells Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Stem Cells Market Value (US$ Bn) Forecast, by Region, 2020 to 2035
  • Figure 02: Global Stem Cells Market Value Share Analysis, By Cell Type, 2024 and 2035
  • Figure 03: Global Stem Cells Market Attractiveness Analysis, By Cell Type, 2020 to 2035
  • Figure 04: Global Stem Cells Market Revenue (US$ Bn), by Embryonic Stem Cells, 2020 to 2035
  • Figure 05: Global Stem Cells Market Revenue (US$ Bn), by Mesenchymal Stem Cells, 2020 to 2035
  • Figure 06: Global Stem Cells Market Revenue (US$ Bn), by Hematopoietic Stem Cells, 2020 to 2035
  • Figure 07: Global Stem Cells Market Revenue (US$ Bn), by Induced Pluripotent Stem Cells, 2020 to 2035
  • Figure 08: Global Stem Cells Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 09: Global Stem Cells Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 10: Global Stem Cells Market Attractiveness Analysis, By Application, 2020 to 2035
  • Figure 11: Global Stem Cells Market Revenue (US$ Bn), by Research, 2020 to 2035
  • Figure 12: Global Stem Cells Market Revenue (US$ Bn), by Clinical, 2020 to 2035
  • Figure 13: Global Stem Cells Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 14: Global Stem Cells Market Attractiveness Analysis, By Indication, 2020 to 2035
  • Figure 15: Global Stem Cells Market Revenue (US$ Bn), by Musculoskeletal Disorders, 2020 to 2035
  • Figure 16: Global Stem Cells Market Revenue (US$ Bn), by Cardiovascular Disorders, 2020 to 2035
  • Figure 17: Global Stem Cells Market Revenue (US$ Bn), by Oncology, 2020 to 2035
  • Figure 18: Global Stem Cells Market Revenue (US$ Bn), by Inflammatory & Autoimmune Diseases, 2020 to 2035
  • Figure 19: Global Stem Cells Market Revenue (US$ Bn), by Neurological Disorders, 2020 to 2035
  • Figure 20: Global Stem Cells Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 21: Global Stem Cells Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 22: Global Stem Cells Market Attractiveness Analysis, By End-user, 2020 to 2035
  • Figure 23: Global Stem Cells Market Revenue (US$ Bn), by Hospitals, 2020 to 2035
  • Figure 24: Global Stem Cells Market Revenue (US$ Bn), by Pharmaceutical & Biotechnology Companies, 2020 to 2035
  • Figure 25: Global Stem Cells Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 26: Global Stem Cells Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 27: Global Stem Cells Market Attractiveness Analysis, By Region, 2020 to 2035
  • Figure 28: North America Stem Cells Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 29: North America Stem Cells Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 30: North America Stem Cells Market Attractiveness Analysis, by Country, 2020 to 2035
  • Figure 31: North America Stem Cells Market Value Share Analysis, By Cell Type, 2024 and 2035
  • Figure 32: North America Stem Cells Market Attractiveness Analysis, By Cell Type, 2020 to 2035
  • Figure 33: North America Stem Cells Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 34: North America Stem Cells Market Attractiveness Analysis, By Application, 2020 to 2035
  • Figure 35: North America Stem Cells Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 36: North America Stem Cells Market Attractiveness Analysis, By Indication, 2020 to 2035
  • Figure 37: North America Stem Cells Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 38: North America Stem Cells Market Attractiveness Analysis, By End-user, 2020 to 2035
  • Figure 39: Europe Stem Cells Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 40: Europe Stem Cells Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 41: Europe Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2020 to 2035
  • Figure 42: Europe Stem Cells Market Value Share Analysis, By Cell Type, 2024 and 2035
  • Figure 43: Europe Stem Cells Market Attractiveness Analysis, By Cell Type, 2020 to 2035
  • Figure 44: Europe Stem Cells Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 45: Europe Stem Cells Market Attractiveness Analysis, By Application, 2020 to 2035
  • Figure 46: Europe Stem Cells Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 47: Europe Stem Cells Market Attractiveness Analysis, By Indication, 2020 to 2035
  • Figure 48: Europe Stem Cells Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 49: Europe Stem Cells Market Attractiveness Analysis, By End-user, 2020 to 2035
  • Figure 50: Asia Pacific Stem Cells Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 51: Asia Pacific Stem Cells Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 52: Asia Pacific Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2020 to 2035
  • Figure 53: Asia Pacific Stem Cells Market Value Share Analysis, By Cell Type, 2024 and 2035
  • Figure 54: Asia Pacific Stem Cells Market Attractiveness Analysis, By Cell Type, 2020 to 2035
  • Figure 55: Asia Pacific Stem Cells Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 56: Asia Pacific Stem Cells Market Attractiveness Analysis, By Application, 2020 to 2035
  • Figure 57: Asia Pacific Stem Cells Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 58: Asia Pacific Stem Cells Market Attractiveness Analysis, By Indication, 2020 to 2035
  • Figure 59: Asia Pacific Stem Cells Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 60: Asia Pacific Stem Cells Market Attractiveness Analysis, By End-user, 2020 to 2035
  • Figure 61: Latin America Stem Cells Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 62: Latin America Stem Cells Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 63: Latin America Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2020 to 2035
  • Figure 64: Latin America Stem Cells Market Value Share Analysis, By Cell Type, 2024 and 2035
  • Figure 65: Latin America Stem Cells Market Attractiveness Analysis, By Cell Type, 2020 to 2035
  • Figure 66: Latin America Stem Cells Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 67: Latin America Stem Cells Market Attractiveness Analysis, By Application, 2020 to 2035
  • Figure 68: Latin America Stem Cells Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 69: Latin America Stem Cells Market Attractiveness Analysis, By Indication, 2020 to 2035
  • Figure 70: Latin America Stem Cells Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 71: Latin America Stem Cells Market Attractiveness Analysis, By End-user, 2020 to 2035
  • Figure 72: Middle East & Africa Stem Cells Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 73: Middle East & Africa Stem Cells Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 74: Middle East & Africa Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2020 to 2035
  • Figure 75: Middle East & Africa Stem Cells Market Value Share Analysis, By Cell Type, 2024 and 2035
  • Figure 76: Middle East & Africa Stem Cells Market Attractiveness Analysis, By Cell Type, 2020 to 2035
  • Figure 77: Middle East & Africa Stem Cells Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 78: Middle East & Africa Stem Cells Market Attractiveness Analysis, By Application, 2020 to 2035
  • Figure 79: Middle East & Africa Stem Cells Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 80: Middle East & Africa Stem Cells Market Attractiveness Analysis, By Indication, 2020 to 2035
  • Figure 81: Middle East & Africa Stem Cells Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 82: Middle East & Africa Stem Cells Market Attractiveness Analysis, By End-user, 2020 to 2035
目次
Product Code: TMRGL86709

Stem Cells Market - Scope of Report

TMR's report on the global stem cells market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global stem cells market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global stem cells market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the stem cells market.

Market Snapshot
Market Value in 2024US$ 92.5 Bn
Market Value in 2035US$ 280.2 Bn
CAGR10.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global stem cells market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global stem cells market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global stem cells market.

The report delves into the competitive landscape of the global stem cells market. Key players operating in the global stem cells market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global stem cells market profiled in this report.

Key Questions Answered in Global stem cells Market Report:

  • What is the sales/revenue generated by stem cells across all regions during the forecast period?
  • What are the opportunities in the global stem cells market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Stem Cells Market - Research Objectives and Research Approach

The comprehensive report on the global stem cells market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global stem cells market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global stem cells market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Stem Cells Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Stem Cells Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Key Industry Events (Partnerships, Collaborations, Mergers, Acquisitions, etc.)
  • 5.2. Overview on Stem Cells
  • 5.3. Pipeline Analysis
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTLE Analysis
  • 5.6. Regulatory Scenario by Key Countries/Regions
  • 5.7. Value Chain Analysis
  • 5.8. Pricing Trends
  • 5.9. Benchmarking of the Products Offered by the Leading Competitors
  • 5.10. Go-to-Market Strategy for New Market Entrants

6. Global Stem Cells Market Analysis and Forecasts, By Cell Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Cell Type, 2020 to 2035
    • 6.3.1. Embryonic Stem Cells (ESCs)
    • 6.3.2. Mesenchymal Stem Cells (MSCs)
    • 6.3.3. Hematopoietic Stem Cells
    • 6.3.4. Induced Pluripotent Stem Cells (iPSCs)
    • 6.3.5. Others
  • 6.4. Market Attractiveness By Cell Type

7. Global Stem Cells Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020 to 2035
    • 7.3.1. Research
    • 7.3.2. Clinical
  • 7.4. Market Attractiveness By Application

8. Global Stem Cells Market Analysis and Forecasts, By Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Indication, 2020 to 2035
    • 8.3.1. Musculoskeletal Disorders
    • 8.3.2. Cardiovascular Disorders
    • 8.3.3. Oncology
    • 8.3.4. Inflammatory & Autoimmune Diseases
    • 8.3.5. Neurological Disorders
    • 8.3.6. Others
  • 8.4. Market Attractiveness By Indication

9. Global Stem Cells Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020 to 2035
    • 9.3.1. Hospitals
    • 9.3.2. Pharmaceutical & Biotechnology Companies
    • 9.3.3. Others
  • 9.4. Market Attractiveness By End-user

10. Global Stem Cells Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Stem Cells Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Cell Type, 2020 to 2035
    • 11.2.1. Embryonic Stem Cells (ESCs)
    • 11.2.2. Mesenchymal Stem Cells (MSCs)
    • 11.2.3. Hematopoietic Stem Cells
    • 11.2.4. Induced Pluripotent Stem Cells (iPSCs)
    • 11.2.5. Others
  • 11.3. Market Value Forecast By Application, 2020 to 2035
    • 11.3.1. Research
    • 11.3.2. Clinical
  • 11.4. Market Value Forecast By Indication, 2020 to 2035
    • 11.4.1. Musculoskeletal Disorders
    • 11.4.2. Cardiovascular Disorders
    • 11.4.3. Oncology
    • 11.4.4. Inflammatory & Autoimmune Diseases
    • 11.4.5. Neurological Disorders
    • 11.4.6. Others
  • 11.5. Market Value Forecast By End-user, 2020 to 2035
    • 11.5.1. Hospitals
    • 11.5.2. Pharmaceutical & Biotechnology Companies
    • 11.5.3. Others
  • 11.6. Market Value Forecast By Country, 2020 to 2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Cell Type
    • 11.7.2. By Application
    • 11.7.3. By Indication
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Stem Cells Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Cell Type, 2020 to 2035
    • 12.2.1. Embryonic Stem Cells (ESCs)
    • 12.2.2. Mesenchymal Stem Cells (MSCs)
    • 12.2.3. Hematopoietic Stem Cells
    • 12.2.4. Induced Pluripotent Stem Cells (iPSCs)
    • 12.2.5. Others
  • 12.3. Market Value Forecast By Application, 2020 to 2035
    • 12.3.1. Research
    • 12.3.2. Clinical
  • 12.4. Market Value Forecast By Indication, 2020 to 2035
    • 12.4.1. Musculoskeletal Disorders
    • 12.4.2. Cardiovascular Disorders
    • 12.4.3. Oncology
    • 12.4.4. Inflammatory & Autoimmune Diseases
    • 12.4.5. Neurological Disorders
    • 12.4.6. Others
  • 12.5. Market Value Forecast By End-user, 2020 to 2035
    • 12.5.1. Hospitals
    • 12.5.2. Pharmaceutical & Biotechnology Companies
    • 12.5.3. Others
  • 12.6. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Cell Type
    • 12.7.2. By Application
    • 12.7.3. By Indication
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Stem Cells Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Cell Type, 2020 to 2035
    • 13.2.1. Embryonic Stem Cells (ESCs)
    • 13.2.2. Mesenchymal Stem Cells (MSCs)
    • 13.2.3. Hematopoietic Stem Cells
    • 13.2.4. Induced Pluripotent Stem Cells (iPSCs)
    • 13.2.5. Others
  • 13.3. Market Value Forecast By Application, 2020 to 2035
    • 13.3.1. Research
    • 13.3.2. Clinical
  • 13.4. Market Value Forecast By Indication, 2020 to 2035
    • 13.4.1. Musculoskeletal Disorders
    • 13.4.2. Cardiovascular Disorders
    • 13.4.3. Oncology
    • 13.4.4. Inflammatory & Autoimmune Diseases
    • 13.4.5. Neurological Disorders
    • 13.4.6. Others
  • 13.5. Market Value Forecast By End-user, 2020 to 2035
    • 13.5.1. Hospitals
    • 13.5.2. Pharmaceutical & Biotechnology Companies
    • 13.5.3. Others
  • 13.6. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Cell Type
    • 13.7.2. By Application
    • 13.7.3. By Indication
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Stem Cells Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Cell Type, 2020 to 2035
    • 14.2.1. Embryonic Stem Cells (ESCs)
    • 14.2.2. Mesenchymal Stem Cells (MSCs)
    • 14.2.3. Hematopoietic Stem Cells
    • 14.2.4. Induced Pluripotent Stem Cells (iPSCs)
    • 14.2.5. Others
  • 14.3. Market Value Forecast By Application, 2020 to 2035
    • 14.3.1. Research
    • 14.3.2. Clinical
  • 14.4. Market Value Forecast By Indication, 2020 to 2035
    • 14.4.1. Musculoskeletal Disorders
    • 14.4.2. Cardiovascular Disorders
    • 14.4.3. Oncology
    • 14.4.4. Inflammatory & Autoimmune Diseases
    • 14.4.5. Neurological Disorders
    • 14.4.6. Others
  • 14.5. Market Value Forecast By End-user, 2020 to 2035
    • 14.5.1. Hospitals
    • 14.5.2. Pharmaceutical & Biotechnology Companies
    • 14.5.3. Others
  • 14.6. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Cell Type
    • 14.7.2. By Application
    • 14.7.3. By Indication
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Stem Cells Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Cell Type, 2020 to 2035
    • 15.2.1. Embryonic Stem Cells (ESCs)
    • 15.2.2. Mesenchymal Stem Cells (MSCs)
    • 15.2.3. Hematopoietic Stem Cells
    • 15.2.4. Induced Pluripotent Stem Cells (iPSCs)
    • 15.2.5. Others
  • 15.3. Market Value Forecast By Application, 2020 to 2035
    • 15.3.1. Research
    • 15.3.2. Clinical
  • 15.4. Market Value Forecast By Indication, 2020 to 2035
    • 15.4.1. Musculoskeletal Disorders
    • 15.4.2. Cardiovascular Disorders
    • 15.4.3. Oncology
    • 15.4.4. Inflammatory & Autoimmune Diseases
    • 15.4.5. Neurological Disorders
    • 15.4.6. Others
  • 15.5. Market Value Forecast By End-user, 2020 to 2035
    • 15.5.1. Hospitals
    • 15.5.2. Pharmaceutical & Biotechnology Companies
    • 15.5.3. Others
  • 15.6. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Cell Type
    • 15.7.2. By Application
    • 15.7.3. By Indication
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. PromoCell
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. AcceGen
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. Bio-Techne
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. Cellular Engineering Technologies, Inc.
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Merck KGaA
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Lonza
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Miltenyi Biotec
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. STEMCELL Technologies.
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. StemBioSys, Inc.
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. CORESTEMCHEMON Inc.
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. PHARMICELL Co., Ltd
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. BlueRock Therapeutics LP
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments